share_log

Prime Medicine Analyst Ratings

Benzinga Analyst Ratings ·  Jan 24, 2023 09:23
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/24/2023 25.45% Morgan Stanley $23 → $21 Maintains Equal-Weight
11/14/2022 61.29% JP Morgan → $27 Initiates Coverage On → Overweight
11/14/2022 49.34% Jefferies → $25 Initiates Coverage On → Buy
11/14/2022 37.4% Morgan Stanley → $23 Initiates Coverage On → Equal-Weight
11/14/2022 31.42% Goldman Sachs → $22 Initiates Coverage On → Neutral

What is the target price for Prime Medicine (PRME)?

There is no price target for Prime Medicine

What is the most recent analyst rating for Prime Medicine (PRME)?

There is no analyst for Prime Medicine

When is the next analyst rating going to be posted or updated for Prime Medicine (PRME)?

There is no next analyst rating for Prime Medicine

Is the Analyst Rating Prime Medicine (PRME) correct?

There is no next analyst rating for Prime Medicine

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment